| Longitudinal study of health, disease and access to care in rural Victoria: the Crossroads-II study: methods KM Glenister, L Bourke, L Bolitho, S Wright, S Roberts, W Kemp, L Rhode, ... BMC Public Health 18, 1-10, 2018 | 20 | 2018 |
| Acute changes in glomerular filtration rate with renin-angiotensin system (RAS) inhibition—good or bad? WR Adam Kidney International 92 (4), 1016, 2017 | | 2017 |
| Integrated and consumer-directed care: a necessary paradigm shift for rural chronic ill health NE Ranson, DR Terry, K Glenister, BR Adam, J Wright Australian Journal of Primary Health 22 (3), 176-180, 2016 | 5 | 2016 |
| Use of renin angiotensin system inhibitors in patients with chronic kidney disease WR Adam, JR Wright Internal Medicine Journal 46 (5), 626-630, 2016 | 2 | 2016 |
| Comment on'A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure'. WR Adam, RC O'Brien Diabetic Medicine 32 (11), 2015 | 10 | 2015 |
| HYPERKALEMIA IN CHRONIC KIDNEY DISEASE: USING PLASMA ALDOSTERONE AND POTASSIUM TO DISTINGUISH BETWEEN HYPOALDOSTERONISM AND RENAL ALDOSTERONE RESISTANCE WR Adam NEPHROLOGY 20, 60-60, 2015 | | 2015 |
| Nonglycemic targets in diabetes D DeWitt, DC Dugdale, WR Adam Medical Clinics 99 (1), 187-200, 2015 | 1 | 2015 |
| Rural clinical school outcomes: what is success and how long do we wait for it? D Garne, M Wilson, IG Wilson The Medical Journal of Australia 201 (10), 575, 2014 | 5 | 2014 |
| The final arbiter of sodium status and extracellular fluid volume is to assess the response to therapy WR Adam Nephrology 10 (19), 597-598, 2014 | | 2014 |
| A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure WR Adam, RC O'Brien Diabetic medicine 31 (9), 1032-1038, 2014 | 38 | 2014 |
| THE IMPORTANCE OF LIFE EXPECTANCY TO ACCEPTABILITY OF A FALL IN GLOMERULAR FILTRATION RATE FOLLOWING RENIN ANGIOTENSIN SYSTEM INHIBITORS WR Adam NEPHROLOGY 19, 76-77, 2014 | | 2014 |
| Safety and efficacy of vemurafenib in end stage renal failure M Iddawela, S Crook, L George, A Lakkaraju, N Nanayakkara, R Hunt, ... BMC cancer 13, 1-4, 2013 | 15 | 2013 |
| Plasma and dialysate potassium concentrations and haemodialysis associated mortality. WR Adam Nephrology 18 (10), 2013 | 4 | 2013 |
| Do fluctuations in plasma creatinine/estimated glomerular filtration rate represent a risk factor for mortality? WR Adam Kidney International 84 (4), 849, 2013 | 2 | 2013 |
| A JUSTIFICATION FOR LESS RESTRICTIVE GUIDELINES ON THE USE OF METFORMIN IN RENAL FAILURE W Adam NEPHROLOGY 18, 42-42, 2013 | | 2013 |
| Trade-off between the benefits of lithium treatment and risk of chronic kidney disease (vol 17, pg 776, 2012) WR Adam, I Schweitzer, RG Walker NEPHROLOGY 18 (1), 79-79, 2013 | | 2013 |
| Trade-off between the benefits of lithium treatment and the risk of chronic kidney disease. WR Adam, I Sshweitzer, RG Walker Nephrology 17 (8), 2012 | 11 | 2012 |
| Utility, or not, of estimates of glomerular filtration rate in modifying drug dosage, with particular reference to enoxaparin WR Adam Internal Medicine Journal 42 (4), 463-466, 2012 | 1 | 2012 |
| Should doctors feel able to practise according to their personal values and beliefs? WR Adam The Medical Journal of Australia 196 (2), 109, 2012 | | 2012 |
| The therapeutic tradeoff between the adverse impacts of a lower GFR and long-term renal protection WR Adam Kidney international 81 (3), 323-324, 2012 | | 2012 |
